This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

EP-024297

Enanta Pharmaceuticals, Inc.

Drug Names(s): EP024297, EP 024297

Description: EP-024297 is a Farnesoid X receptor (FXR) agonist compound being developed by Enanta.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug